Goldman Sachs
ALIM

Goldman Sachs’s Alimera Sciences ALIM Stock Holding History

Goldman Sachs’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-71,758
Closed -$280K – 5999
2024
Q1 		$280K Buy
+71,758
New +$273K ﹤0.01% 5003
2018
Q4 		– Sell
-828
Closed -$12K – 5769
2018
Q3 		$12K Sell
828
-581
-41% -$8.84K ﹤0.01% 5462
2018
Q2 		$21K Buy
1,409
+72
+5% +$1.01K ﹤0.01% 5490
2018
Q1 		$21K Hold
1,337
– – ﹤0.01% 5665
2017
Q4 		$27K Sell
1,337
-6,587
-83% -$129K ﹤0.01% 6071
2017
Q3 		$160K Sell
7,924
-12,331
-61% -$264K ﹤0.01% 5880
2017
Q2 		$422K Sell
20,255
-13,685
-40% -$293K ﹤0.01% 5232
2017
Q1 		$713K Sell
33,940
-20,298
-37% -$391K ﹤0.01% 4691
2016
Q4 		$879K Sell
54,238
-10,633
-16% -$195K ﹤0.01% 4571
2016
Q3 		$1.45M Sell
64,871
-43,518
-40% -$1M ﹤0.01% 4075
2016
Q2 		$2M Sell
108,389
-33,267
-23% -$885K ﹤0.01% 3620
2016
Q1 		$3.72M Buy
141,656
+33,951
+32% +$1.06M ﹤0.01% 2945
2015
Q4 		$3.91M Buy
107,705
+241
+0.2% +$10.5K ﹤0.01% 3065
2015
Q3 		$3.56M Buy
107,464
+83,718
+353% +$4.71M ﹤0.01% 3203
2015
Q2 		$1.64M Buy
23,746
+20,829
+714% +$1.44M ﹤0.01% 4037
2015
Q1 		$219K Buy
2,917
+1,351
+86% +$106K ﹤0.01% 5942
2014
Q4 		$130K Sell
1,566
-8,033
-84% -$652K ﹤0.01% 6447
2014
Q3 		$780K Buy
9,599
+3,682
+62% +$314K ﹤0.01% 4864
2014
Q2 		$531K Sell
5,917
-3,283
-36% -$292K ﹤0.01% 5258
2014
Q1 		$1.09M Buy
9,200
+5,981
+186% +$581K ﹤0.01% 4594
2013
Q4 		$227K Buy
+3,219
New +$131K ﹤0.01% 5881

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs's ALIM Position: Q2 2024 in Review

Goldman Sachs sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 71,758 shares — an estimated $280K sold.

Goldman Sachs first reported a position in ALIM in Q4 2013 and held it in 21 quarters. The position peaked at $3.91M in Q4 2015. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Goldman Sachs reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 71,758 Alimera Sciences shares in Q2 2024, an estimated $280K.
  • Goldman Sachs first reported a position in Alimera Sciences in Q4 2013 and held it in 21 quarters.
  • Goldman Sachs's Alimera Sciences position peaked at $3.91M in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.